Skip to main content

​
Measure Details

Report on the percentage of patients 18-75 years of age with diabetes who had who had a glycemic status assessment (hemoglobin A1c [HbA1c] or glucose management indicator [GMI]) > 9.0% during the measurement period. This is a reverse measure; the goal is to ensure patients keep their A1c < 9%. Practices should try to lower their percentage for this reverse measure.

​
Measure Parameters

Numerator: Patients whose most recent glycemic status assessment (HbA1c or GMI) (performed during the measurement period) is >9.0% or is missing, or was not performed during the measurement period. Denominator: Patients 18-75 years of age with diabetes with a visit during the measurement period. Exclusions/Exceptions:
  • Exclude patients who are in hospice care for any part of the measurement period.
  • Exclude patients 66 and older by the end of the measurement period who are living long term in a nursing home any time during the measurement period.
  • Exclude patients 66 and older by the end of the measurement period with an indication of frailty for any part of the measurement period who meet any of the following criteria:
    • Advanced illness diagnosis during the measurement period or the year prior
    • OR taking dementia medications during the measurement period or the year prior
  • Exclude patients receiving palliative care for any part of the measurement period.
The qualifying exclusion tags for this measure are called (Reference: Tag Reports and Notes with Document Tags):
  • EXCLUSION: HOSPICE CARE
  • EXCLUSION: IP DISCHARGE STATUS TO HEALTH CARE FACILITY FOR HOSPICE CARE
  • EXCLUSION: IP DISCHARGE STATUS TO HOME FOR HOSPICE CARE

​
How to document frailty in Elation

To document frailty in Elation, both conditions below have to be met:
  1. add a frailty diagnosis to the patient’s Problem List
  2. meet one of the following criteria:
  3. record an advanced illness diagnosis in 2 outpatient encounters
  4. record an advanced illness in 1 inpatient counter
  5. record a dementia medication in the patient’s chart
Attachments with frailty codes and advanced illness codes can be found in the Attachments section of this article.
You can also document the use of a frailty device to claim the first part of the exclusion. To do so, please add a document tag that represents the frailty device to a visit note from the reporting year. The document tag should have the device code and description and can be created directly in the visit note or within your Document Tags Settings page in Elation. Attachments with device codes are also in the Attachments section of this article. Elation Workflows
Elation has implemented dedicated workflows that reflect standardized requirements we do not control for certification to ensure structured and reportable tracking of measure specifications for supported electronic Clinical Quality Measures. To optimize performance per the specifications, please adhere precisely to the workflows outlined in the referenced Help Center article.
  1. Ensure the patient has a diagnosis of Diabetes (E11.9, etc):
Image
  1. Receive HbA1c Labs from a Lab Vendor electronically through Elation
  2. Manually document a patient’s HbA1c Results.
  3. The HbA1c can be recorded in a structured format by clicking “Actions” next to an uploaded report and then selecting “Add Lab Values for Trending.”
  • Reference: How to record structured lab results from in-house or faxed lab report
Image
  1. Clicking “Notes” -> “Point-of-Care Labs”
  • Reference: How to use the Point-of-Care Labs feature
Measure Information Diabetes is the seventh leading cause of death in the United States. In 2017, diabetes affected approximately 34 million Americans (10.5% of the U.S. population) and killed approximately 84,000 people (Centers for Disease Control and Prevention [CDC], 2020a). Diabetes is a long-lasting disease marked by high blood glucose levels, resulting from the body’s inability to produce or use insulin properly (CDC, 2020a). People with diabetes are at increased risk of serious health complications including vision loss, heart disease, stroke, kidney damage, and amputation of feet or legs (CDC, 2018). In 2017, diabetes cost the U.S. an estimated 327billion:327 billion: 237 billion in direct medical costs and 90billioninreducedproductivity.Thisisa3490 billion in reduced productivity. This is a 34% increase from the estimated 245 billion spent on diabetes in 2012 (American Diabetes Association [ADA], 2018). Controlling A1c blood levels helps reduce the risk of microvascular complications (eye, kidney and nerve diseases) (ADA, 2020). Reference: Measure Information from CMS

​
Additional Information/FAQ

Although this measure can be satisfied by manually entering lab results, we recommend getting interfaced lab results, if possible. Electronic lab results directly from the lab will also count towards this measure, limiting the need for additional documentation.

​
Attachments